UNLOCKING PRECISION IN DERMATOLOGICAL CARE
The SRT-100 Vision represents the latest advancement in superficial radiotherapy (the only FDA cleared IG-SRT) technology, combining the proven efficacy of the SRT-100 system with advanced high-frequency ultrasound capabilities. This innovative device, developed by Sensus Healthcare, offers enhanced precision and treatment planning, revolutionizing the way dermatological conditions are treated.
The SRT-100 Vision incorporates high-resolution imaging technology directly into the treatment system, allowing for real-time visualization of the treatment area during therapy sessions.
With the ability to visualize the target area in real-time, the SRT-100 Vision enables clinicians to precisely delineate the treatment field and optimize treatment plans for each patient, ensuring maximum efficacy and minimal side effects.
By providing immediate feedback on treatment delivery, the SRT-100 Vision enhances treatment accuracy, minimizing the risk of under- or over-treatment and reducing the need for re-treatment.
The integration of imaging technology into the treatment system streamlines the treatment process, reducing treatment time and improving overall patient experience.
The SRT-100 Vision offers customizable treatment options to accommodate the unique needs of each patient, including adjustable energy levels and treatment parameters.
During a treatment session with the SRT-100 Vision, patients undergo imaging of the treatment area to precisely delineate the target area. Once the treatment field is defined, the device delivers targeted radiotherapy to the affected area while simultaneously monitoring treatment delivery in real-time. The entire process is guided by the integrated imaging technology, ensuring accurate and precise treatment delivery.
